chr10-34119721-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001184785.2(PARD3):c.3560C>T(p.Thr1187Met) variant causes a missense change. The variant allele was found at a frequency of 0.0012 in 1,611,664 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0063 ( 9 hom., cov: 33)
Exomes 𝑓: 0.00067 ( 7 hom. )
Consequence
PARD3
NM_001184785.2 missense
NM_001184785.2 missense
Scores
4
14
Clinical Significance
Conservation
PhyloP100: 3.93
Genes affected
PARD3 (HGNC:16051): (par-3 family cell polarity regulator) This gene encodes a member of the PARD protein family. PARD family members interact with other PARD family members and other proteins; they affect asymmetrical cell division and direct polarized cell growth. Multiple alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0062744617).
BP6
Variant 10-34119721-G-A is Benign according to our data. Variant chr10-34119721-G-A is described in ClinVar as [Benign]. Clinvar id is 3039204.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00634 (965/152324) while in subpopulation AFR AF= 0.0214 (890/41568). AF 95% confidence interval is 0.0202. There are 9 homozygotes in gnomad4. There are 459 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 965 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PARD3 | NM_001184785.2 | c.3560C>T | p.Thr1187Met | missense_variant | 24/25 | ENST00000374788.8 | NP_001171714.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PARD3 | ENST00000374788.8 | c.3560C>T | p.Thr1187Met | missense_variant | 24/25 | 1 | NM_001184785.2 | ENSP00000363920.3 |
Frequencies
GnomAD3 genomes AF: 0.00633 AC: 964AN: 152208Hom.: 9 Cov.: 33
GnomAD3 genomes
AF:
AC:
964
AN:
152208
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00167 AC: 413AN: 246686Hom.: 6 AF XY: 0.00124 AC XY: 166AN XY: 134096
GnomAD3 exomes
AF:
AC:
413
AN:
246686
Hom.:
AF XY:
AC XY:
166
AN XY:
134096
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000667 AC: 973AN: 1459340Hom.: 7 Cov.: 32 AF XY: 0.000551 AC XY: 400AN XY: 725670
GnomAD4 exome
AF:
AC:
973
AN:
1459340
Hom.:
Cov.:
32
AF XY:
AC XY:
400
AN XY:
725670
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00634 AC: 965AN: 152324Hom.: 9 Cov.: 33 AF XY: 0.00616 AC XY: 459AN XY: 74484
GnomAD4 genome
AF:
AC:
965
AN:
152324
Hom.:
Cov.:
33
AF XY:
AC XY:
459
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
94
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
231
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
PARD3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 06, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;T;.;.;.;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D;D;D;D;D;D;D
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;N;.;.;.;.;.
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;N;N;N;N;N
REVEL
Benign
Sift
Uncertain
D;D;D;D;D;D;D;D
Sift4G
Uncertain
T;D;D;D;T;T;T;D
Polyphen
P;.;P;P;P;P;P;.
Vest4
MVP
MPC
0.13
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at